吉利德科学Gilead Sciences（GILD）2025年第二季度财报（10-Q）「NASDAQ」（英文版）（89页）.pdf

1、UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON,D.C.20549 FORM 10-QQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended June 30,2025orTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For t

2、he transition period from _ to _Commission File No.0-19731 GILEAD SCIENCES,INC.(Exact Name of Registrant as Specified in Its Charter)Delaware94-3047598(State or Other Jurisdiction of Incorporation or Organization)(IRS Employer Identification No.)333 Lakeside Drive,Foster City,California 94404(Addres

3、s of principal executive offices)(Zip Code)650-574-3000(Registrants Telephone Number,Including Area Code)Securities registered pursuant to Section 12(b)of the Act:Title of each classTrading Symbol(s)Name of each exchange on which registeredCommon Stock,par value,$0.001 per shareGILDThe Nasdaq Global

4、 Select MarketIndicate by check mark whether the registrant:(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of 1934during the preceding 12 months(or for such shorter period that the registrant was required to file such reports),and(2)has been subjec

5、t to such filingrequirements for the past 90 days.Yes x No Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 ofRegulation S-T(232.405 of this chapter)during the preceding 12 months(or for such shorter

6、period that the registrant was required to submit suchfiles).Yes x No Indicate by check mark whether the registrant is a large accelerated filer,an accelerated filer,a non-accelerated filer,a smaller reporting company or anemerging growth company.See the definitions of“large accelerated filer,”“acce